Nordmark Pharma Overview
- Year Founded
-
1927
- Status
-
Acquired/Merged
- Employees
-
600
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
- Investments
-
1
Nordmark Pharma General Information
Description
Manufacturer of active biological and biotechnological ingredients and medicinal products intended to offer different grades of Collagenase NB products. The company specializes in the production of pancreatin and collagenase which includes the extraction of biological starting materials, microbial fermentation, and the extraction of active ingredients from cell cultures for wound treatment ointments and biochemicals.
Contact Information
Website
www.nordmark-pharma.de(Operating Subsidiary)
Corporate Office
- Pinnauallee 4
- 25436 Uetersen
- Germany
Corporate Office
- Pinnauallee 4
- 25436 Uetersen
- Germany
Nordmark Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Nordmark Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nordmark Pharma Patents
Nordmark Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4625425-A1 | A computer-implemented method for monitoring and documenting process steps in a laboratory and a respective device | Inactive | 27-Mar-2024 | ||
| CA-3236097-A1 | Culture medium for cultivating hathewaya histolytica (or clostridium histolyticum) and the production of one or more proteases | Pending | 05-Jan-2022 | ||
| EP-4388079-A1 | Culture medium for cultivating hathewaya histolytica (or clostridium histolyticum) and the production of one or more proteases | Pending | 05-Jan-2022 | ||
| US-20260357235-A1 | Culture medium for cultivating hathewaya histolytica (or clostridium histolyticum) and the production of one or more proteases | Pending | 05-Jan-2022 | ||
| WO-2023131588-A1 | Culture medium for cultivating hathewaya histolytica (or clostridium histolyticum) and the production of one or more proteases | Inactive | 05-Jan-2022 | C12N1/20 |
Nordmark Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nordmark Pharma Investments (1)
Nordmark Pharma’s most recent deal was a Joint Venture with Norbitec. The deal was made on 27-Feb-2003.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Norbitec | 27-Feb-2003 | Joint Venture | Pharmaceuticals |
Nordmark Pharma FAQs
-
When was Nordmark Pharma founded?
Nordmark Pharma was founded in 1927.
-
Where is Nordmark Pharma headquartered?
Nordmark Pharma is headquartered in Uetersen, Germany.
-
What is the size of Nordmark Pharma?
Nordmark Pharma has 600 total employees.
-
What industry is Nordmark Pharma in?
Nordmark Pharma’s primary industry is Biotechnology.
-
Is Nordmark Pharma a private or public company?
Nordmark Pharma is a Private company.
-
What is Nordmark Pharma’s current revenue?
The current revenue for Nordmark Pharma is .
-
When was Nordmark Pharma acquired?
Nordmark Pharma was acquired on 01-Jan-2001.
-
Who acquired Nordmark Pharma?
Nordmark Pharma was acquired by BASF.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
